Transparency and control of clinical trials

This procedure concerns rules for transparency and control in clinical trials. It aims to ensure that information about trials is publicly available and that trials are conducted under strict oversight.

This affects patients, researchers, pharmaceutical companies, and regulatory bodies. It enhances public trust and safety in medical research and treatments.